FDA Inspection 1271861 — Andrzej Lewinski, MD, Ph.D.
The FDA completed an inspection of Andrzej Lewinski, MD, Ph.D. on March 14, 2025 in Lodz. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- March 14, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Lodz (Poland)
Additional Details
Clinical Investigator (CI)